Russell Investments Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,278
| Closed | -$6.93K | – | 3916 |
|
|
2024
Q4 | $6.93K | Buy |
2,278
+2,080
| +1,051% | +$6.32K | ﹤0.01% | 3217 |
|
|
2024
Q3 | $1.03K | Sell |
198
-5
| -2% | -$26 | ﹤0.01% | 3476 |
|
|
2024
Q2 | $522 | Buy |
203
+36
| +22% | +$93 | ﹤0.01% | 3498 |
|
|
2024
Q1 | $822 | Buy |
+167
| New | +$822 | ﹤0.01% | 3154 |
|
|
2023
Q4 | – | Sell |
-182
| Closed | -$2.09K | – | 3327 |
|
|
2023
Q3 | $2.09K | Sell |
182
-58,493
| -100% | -$671K | ﹤0.01% | 3256 |
|
|
2023
Q2 | $1.49M | Buy |
58,675
+30,271
| +107% | +$766K | ﹤0.01% | 1728 |
|
|
2023
Q1 | $915K | Sell |
28,404
-51,094
| -64% | -$1.65M | ﹤0.01% | 2020 |
|
|
2022
Q4 | $1.47M | Sell |
79,498
-74,730
| -48% | -$1.38M | ﹤0.01% | 1772 |
|
|
2022
Q3 | $4.16M | Buy |
154,228
+118,685
| +334% | +$3.2M | 0.01% | 1147 |
|
|
2022
Q2 | $490K | Sell |
35,543
-4,274
| -11% | -$58.9K | ﹤0.01% | 2279 |
|
|
2022
Q1 | $775K | Sell |
39,817
-11,694
| -23% | -$228K | ﹤0.01% | 2075 |
|
|
2021
Q4 | $840K | Buy |
+51,511
| New | +$840K | ﹤0.01% | 2242 |
|
|
2021
Q3 | – | Sell |
-5,835
| Closed | -$172K | – | 3248 |
|
|
2021
Q2 | $172K | Hold |
5,835
| – | – | ﹤0.01% | 2949 |
|
|
2021
Q1 | $163K | Buy |
+5,835
| New | +$163K | ﹤0.01% | 2882 |
|
|
2020
Q4 | – | Sell |
-52,050
| Closed | -$1.31M | – | 3224 |
|
|
2020
Q3 | $1.31M | Buy |
52,050
+15,054
| +41% | +$378K | ﹤0.01% | 1932 |
|
|
2020
Q2 | $902K | Buy |
+36,996
| New | +$902K | ﹤0.01% | 2116 |
|
|
2019
Q4 | – | Sell |
-11,900
| Closed | -$155K | – | 3149 |
|
|
2019
Q3 | $155K | Sell |
11,900
-18,613
| -61% | -$242K | ﹤0.01% | 2696 |
|
|
2019
Q2 | $396K | Buy |
+30,513
| New | +$396K | ﹤0.01% | 2338 |
|
|
2017
Q1 | – | Sell |
-8,290
| Closed | -$174K | – | 3098 |
|
|
2016
Q4 | $174K | Buy |
+8,290
| New | +$174K | ﹤0.01% | 2740 |
|